NCT00556257View on ClinicalTrials.gov

Study Of JAK3 Inhibitor For The Prevention Of Acute Rejection In Kidney Transplant Patients

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2007

Conditions
Kidney Transplantation
Interventions
DRUG

Cyclosporine

Standard of care

DRUG

CP-690-,550

CP-690550 20 mg BID in Months 1-6 then 15 mg BID in Months 7-12

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY